District Court in 9th Circuit Finds That Heightened Pleading Standard Applies to All Prongs of False Patent Marking Claim

October 11, 2024

Reading Time : 2 min

The Central District of California ruled that the heightened pleading standard of Federal Rule of Civil Procedure 9(b) applies to all three prongs of a false patent marking claim, including the third prong, competitive injury. In doing so, took a clear stand on an issue with a nationwide split among district courts.

After being sued for infringing two patents directed to magnetic building tiles, defendant filed counterclaims alleging false patent marking under 35 U.S.C. § 292(a). Defendant alleged that plaintiff had marked its products with the now-abandoned U.S. patent application, No. 17/140,367 (“the ’367 application”) and that the statement “patent pending” on its website was false because the ’367 application was no longer alive.

Plaintiff filed a motion to dismiss the counterclaim. To survive a motion to dismiss under the Iqbal/Twombly standard, a counterclaim “must contain sufficient factual matter, accepted as true, to ‘state a claim to relief that is plausible on its face.’” The allegations cannot be merely conclusory or based on unreasonable inferences. Under Rule 9(b), when alleging fraud, a party “must state with particularity the circumstances constituting fraud.”

 In the case of a false patent marking claim, defendant must plead sufficient facts to show that plaintiff (1) marked an unpatented article and (2) intended to deceive the public by doing so. This requires an intent to deceive the public and sounds in fraud, in accordance with the Rule 9(b) pleading requirements. To show an intent to deceive, there must be an objective indication to reasonably infer that the party was aware that the patent expired, such that a general allegation that they knew or should have known is insufficient.

For a false patent marking claim, defendant must also show that the defendant (3) suffered a competitive injury as a result of a violation of the marking statute. The court recognized that there was a split among district courts as to whether the heightened Rule 9(b) requirements applied to the competitive injury requirement, with some courts only applying the standard to the first two elements.

The court concluded that defendant had stated with particularity that plaintiff used patents and patent applications to advertise its products to consumers, meeting the first element, but did not find that defendant alleged facts from which the court could make a reasonable inference that there was an intent to deceive.

As to the third element, the court recognized the split in authority, but found that 9thCircuit jurisprudence was clear that the Rule 9(b) pleading requirement applied to false patent marking claims in their entirety. Similarly, although the Federal Circuit had not spoken on the issue, precedent from that tribunal further supported this conclusion. Therefore, the court also applied Rule 9(b)’s heightened pleading standard to the third element, competitive injury. However, regardless of whether the heightened pleading standard applied, the court concluded that defendant did not allege sufficient facts to show competitive injury.

The court granted plaintiff’s motion to dismiss on the ground that defendant failed to sufficiently plead two of the three prongs required for false patent marking: intent to deceive and competitive injury.

Practice Tip: In at least the Central District of California, a party alleging a false patent marking claim should recognize that the entire claim is subject to the heightened pleading standard of Rule 9(b), and should plead accordingly. Aside from well-pleaded factual allegations showing that plaintiff marked an unpatented and article and intended to deceive, this also includes alleging particular instances (avoiding conclusory or speculative allegations without factual support) sufficient to show competitive injury caused by the other party.

Squaregles LLC v. Laltitude LLC, No. 2:23-cv-09751-CBM-(BFMx) (C.D. Cal. July 2, 2024).

Share This Insight

Previous Entries

IP Newsflash

March 24, 2025

The Federal Circuit affirmed a Patent Trial and Appeal Board (PTAB) final written decision holding that the prior art exception of AIA Section 102(b)(2)(B) does not apply to a prior sale by an inventor when the sale is conducted in private. According to the Federal Circuit, a sale must disclose the relevant aspects of the invention to the public to qualify for the prior art exception of Section 102(b)(2)(B).

...

Read More

IP Newsflash

March 21, 2025

Under the Lanham Act, a plaintiff who prevails on a trademark infringement claim may be entitled to recover the “defendant’s profits” as damages. The Supreme Court in Dewberry Group, Inc. v. Dewberry Engineers Inc. unanimously construed “defendant’s profits” in 35 USC § 1117(a) to mean that only the named defendant’s profits can be awarded, not the profits of other related corporate entities. The Court, however, left open the possibility that other language in § 1117(a) may allow for damages linked to the profits of related entities, if properly raised and supported.

...

Read More

IP Newsflash

March 13, 2025

In a series of rulings on a motion in limine, the District of Delaware recently distinguished between what qualifies as being incorporated by reference and what does not for the purposes of an anticipation defense. In short, a parenthetical citation was held to be insufficient, while three passages discussing a cited reference met the test.

...

Read More

IP Newsflash

March 4, 2025

On February 28, 2025, the USPTO announced that it was rescinding former Director Vidal’s 2022 memorandum on discretionary denials by the Patent Trial and Appeal Board. The 2022 memorandum effectively narrowed the application of discretionary denials in cases with parallel district court litigation by specifying instances where discretionary denial could not be issued. With the withdrawal of the memorandum, individual PTAB panels will regain flexibility in weighing discretionary denials. While the long-term effect of that increased flexibility is not yet known, the immediate effect is likely to be a shift towards the discretionary analysis applied by PTAB panels before the issuance of the memorandum.

...

Read More

IP Newsflash

March 3, 2025

A District of Delaware judge recently granted a defendant’s motion to include a patent prosecution bar in its proposed protective order after determining that litigation counsel’s ability to practice before the Patent Office—without ever having represented the plaintiffs at the Patent Office in the past—weighed heavily in favor of the bar.

...

Read More

IP Newsflash

February 12, 2025

The Federal Circuit recently reversed a district court decision that found a patent that did not describe after-arising technology failed to satisfy the written description requirement. In so doing, the Federal Circuit explained that written description and enablement are evaluated based on the subject matter that is claimed, not the products that practice those claims. As a result, the patentee was not required to describe unclaimed, later-discovered features of the accused products despite the broad language in the claims that undisputedly covered the products.

...

Read More

IP Newsflash

January 24, 2025

The District of Delaware recently rejected a patentee’s argument that non-production of an opinion letter from counsel, combined with knowledge of the patent, warranted a finding that defendant induced infringement.

...

Read More

IP Newsflash

January 17, 2025

The District of Delaware recently denied a motion to dismiss a patent infringement complaint involving gene editing technology that sought relief under the Safe Harbor Provision of the Hatch-Waxman Act. Specifically, the court found the patentee’s complaint sufficiently alleged at least some uses of the claimed technology that, when taken as true, were not solely uses of a “patented invention” that were “reasonably related” to an FDA submission.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.